Porter James Richard 4
4 · Nuvalent, Inc. · Filed Oct 17, 2025
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Porter James Richard
DirectorPresident and CEO
Transactions
- Sale
Class A Common Stock
2025-10-16$92.19/sh−1,114$102,700→ 249,762 total - Sale
Class A Common Stock
2025-10-16$92.63/sh−700$64,841→ 249,062 total - Sale
Class A Common Stock
2025-10-16$90.91/sh−13,876$1,261,467→ 250,876 total - Sale
Class A Common Stock
2025-10-16$90.01/sh−11,310$1,018,013→ 264,752 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-16−27,000→ 222,400 totalExercise: $18.93Exp: 2032-01-04→ Class A Common Stock (27,000 underlying) - Exercise/Conversion
Class A Common Stock
2025-10-16$18.93/sh+27,000$511,110→ 276,062 total
Footnotes (6)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 2, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.56 to $90.55, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.56 to $91.47, inclusive.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.60 to $92.57, inclusive.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.62 to $92.69, inclusive.
- [F6]The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.